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Abstract
Here we present a series of infiltrative ductal carcinoma breast cases (infiltrative ductal carcinoma
with central necrosis) so closely mimicking 'DCIS with central comedo necrosis' that on initial
morphological analysis these foci of tumors were labeled as DCIS (high grade, comedo). However
on further histological work up and by using immunohistochemistry (IHC) for myoepithelial
markers it was later confirmed that these were foci of infiltrative ductal carcinoma breast with
central necrosis. This case series gives the realization that a breast carcinoma may be partly or
entirely DCIS like yet invasive. In such a dilemma IHC especially for assessment of myoepithelial
lining is very useful to differentiate DCIS comedo from invasive carcinoma with central necrosis.
Background
Proliferation of malignant epithelial cells within the ducts
of the breast that show no light microscopic evidence of
invasion through the basement membrane into the sur-
rounding stroma is known as ductal carcinoma in situ
(DCIS)[1]. Several morphologic patterns of DCIS are rec-
ognized, the most common of which are comedo, cribri-
form, solid, micro papillary and papillary. DCIS-comedo
is diagnosed when at least one duct in the breast is filled
and expanded by large, markedly atypical cells and has
abundant central luminal necrosis [1]. It is well appreci-
ated that infiltrating ductal carcinoma breast may mimic
the diverse patterns of DCIS, the prototype of this being
the infiltrating cribriform carcinoma [2].
Similarly here for the first time we present a series of infil-
trative breast cancer cases (Infiltrative ductal carcinoma
with central necrosis) so closely mimicking 'DCIS with
central comedo necrosis' that on initial morphological
analysis these tumors or foci were labeled as DCIS (high
grade, comedo). However when axillary nodes were sam-
pled, very similar morphologic pattern was seen in lymph
node metastasis prompting immunohistochemical (IHC)
studies on original biopsies with myoepithelial & base-
ment membrane markers. This revealed a deficient/absent
basement membrane & myoepithelial layer confirming
the infiltrative nature of the initially diagnosed comedo
type DCIS.
Case Presentations
Case 1
A 56 year old woman presented with a breast lump of 3 ×
2 × 1.5 cm in size submitted entirely. On histology it was
reported as extensive DCIS comedo with no invasive com-
ponent (Figure 1). On follow up examination axillary
nodes became palpable and lymph node sampling was
done. On histology one out of 14 lymph nodes showed
'metastatic breast carcinoma with central necrosis' closely
mimicking DCIS comedo (Figure 2) in addition to some
classic invasive foci. Breast lump slides were reviewed
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again with immunohistochemical staining for myoepithe-
lium. All the foci which were interpreted as DCIS comedo
lacked myoepithelial layer confirming the invasive nature
of the tumor (Figure 3).
Case 2
A 60 year old woman presented with a breast lump of 5.5
× 3 × 2.5 cm extensively sampled. On histology it was
assessed as extensive comedo DCIS with occasional foci of
invasion. However 35 out of 38 axillary lymph nodes
showed extensive metastasis with pattern largely identical
to what was reported high grade comedo DCIS. IHC for
myoepithelial markers on original biopsy specimen again
confirmed invasive nature of the DCIS comedo like foci
with lack of myoepithelium.
Case 3
A 45 year old woman's breast lump was reported as infil-
trating ductal carcinoma (20%) with high grade DCIS
Comedo (80%).Three out of twenty Lymph nodes
showed extensive metastasis with similar DCIS Comedo
like pattern. IHC again confirmed the invasive nature of
the foci what was initially called as high grade DCIS. The
size of the invasive component was recalculated for stag-
ing as IDC (70%); DCIS Comedo (30%).
Case 4
A 42 year old woman presented with a breast lump of 2.5
× 2 × 2 cm reported as high grade comedo type DCIS.
Lymph nodes were negative. Estrogen Receptor was posi-
tive, Progesterone Receptor was negative and HER2 by
IHC was 3+ in what was called DCIS Oncologist denied
the role of Herceptin as a part of therapy as HER2 expres-
sion was in DCIS only with no invasive component
present. On review and IHC for myoepithelium, these foci
lacked the myoepithelial layer and were relabeled as inva-
sive carcinoma with central necrosis. Subsequently the
patient was treated with Herceptin.
Discussion
The risk factors for the development of invasive breast
cancer and DCIS are similar. A further dilemma in the
classification and histological analysis of DCIS is micro
Same tumor as shown in Fig 1 stained with a cocktail of myo pithelial markersFigure 3
Same tumor as shown in Fig 1 stained with a cocktail of 
myoepithelial markers. Note absent myoepithelial layer con-
sistent with the diagnosis of infiltrating ductal carcinoma with 
central necrosis. Mag: 10×.
Breast lump showing infiltrating carcinoma breast with cen-tral necrosis initially interpreted as DCIS-comedo, H & E, M g: 4×Figure 1
Breast lump showing infiltrating carcinoma breast with cen-
tral necrosis initially interpreted as DCIS-comedo, H & E, 
Mag: 4×.
Axillary lymph node of the same patient showing metastatic duct l carcinoma breast with central necrosis closely mimick-ing DCIS wit  com do necrosis, H & E, Mag: 2×Fi ure 2
Axillary lymph node of the same patient showing metastatic 
ductal carcinoma breast with central necrosis closely mimick-
ing DCIS with comedo necrosis, H & E, Mag: 2×.
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invasion. DCIS with micro invasion (DCISM) may also
result in axillary lymph node metastases, whereas patients
with DCIS should not, by definition, have axillary metas-
tases. A higher suspicion for axillary metastases with
DCISM can be obtained from the primary tumor charac-
teristics. Statistically significant independent predictors of
lymph node metastases in DCISM are comedo DCIS (P <
0.03) and the number of DCIS-involved ducts (P < 0.002)
[1].
On pure morphological assessment a potential diagnostic
trap is invasive ductal carcinoma with central necrosis. As
the name indicates the tumor has a comedo DCIS like
appearance and is likely to be diagnosed as DCIS comedo
while in reality it is infiltrative breast carcinoma with cen-
tral necrosis. This situation is identical to invasive cribi-
form carcinoma, a rare form of breast malignancy which
very closely mimics cribriform DCIS [2]. The most impor-
tant aspect of this concept is the realization that a breast
carcinoma may be partly or entirely DCIS like, yet inva-
sive. Recently a solid variant of invasive cribriform carci-
noma is also described [3]. Similar morphologic patterns
are also seen in salivary duct tumors, sweat gland carcino-
mas [4] and high grade prostatic adenocarcinomas. In
case of the entire morphology having this feature, it is pos-
sible to report primary tumor as DCIS, following a con-
servative approach without further work up or axillary
lymph node sampling. The other more common scenario
is to incorrectly asses the size of the invasive component
resulting in incorrect pTNM staging and management as
pathological tumor size for classification (pT) is a meas-
urement of only the invasive component [5].
In such a dilemma IHC is very useful in assessment of
invasion. In the ideal world invasive cancers are character-
ized by lack of both basement membrane and myoepithe-
lial cells. However in the real world while invasive cancer
lacks myoepithelial cells, some produce basement mem-
brane components adding further to the confusion.
Therefore for the assessment of DCIS and invasive
comedo DCIS assessment of myoepithelial lining is most
reliable. A number of myoepithelial markers including S-
100, Alpha smooth muscle Actin, SMM – HC, Calponin
and HMW-CK are available with different sensitivities and
specificities. SMM-HC is thought to be the most specific
while other though quite sensitive but are less specific.
Some other myoepithelial markers include Maspin, CD10
and P63. Amongst these markers P63 is particularly useful
as it stains the myoepithelial nuclei only with high sensi-
tivity and specificity [6]. Myoepithelial antibody cocktail
is another good choice [7]. With Actin one should be par-
ticularly careful not to confuse periductal myofibroblast
staining as myoepithelial staining. In routine surgical
pathology practice however it is not practical to do IHC
for myoepithelium routinely on all such cases. One mor-
phologic feature which we found useful on H & E was the
concentric stromal reaction around these invasive foci
(Fig 4). In addition irregular circumference of these inva-
sive foci compared to true DCIS comedo was also helpful.
Conclusion
The number of new breast cancer cases especially DCIS
have increased multifold over the past decade owing to
improved diagnostic testing especially mammography.
This potential serious diagnostic error confusing high
grade DCIS comedo with invasive carcinoma with central
necrosis may be avoided by using IHC staining for myoep-
ithelial markers and at times by subtle morphologic clues
like stromal reaction.
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Foci of invasive ductal carcinoma breast with central necro-
sis. Note concentric stromal reaction around these foci 
(arrow), a helpful morphologic feature. H & E, Mag: 4×.
Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Medical Case Reports 2007, 1:83 http://www.jmedicalcasereports.com/content/1/1/83
Page 4 of 4
(page number not for citation purposes)
References
1. Leonard GD, Swain SM: Ductal carcinoma in Situ, Complexities
and Challenges.  Natl Cancer Inst 2004, 16; 96:906-20.
2. Venable JG, Schwartz AM, Silverberg SG: Infiltrating cribriform
carcinoma of the breast: a distinctive clinicopathologic
entity.  Hum Pathol 1990, 21:333-8.
3. Sanders ME, Page DL, Simpson JA, Edgerton ME, Jensen RA: Solid
variant of cribriform carcinoma a study of 24 cases.
(Abstract).  Mod Path 2003, 16:45.
4. Wick MR, Ockner DM, Mills SE, Ritter JH, Swanson PE: Homolo-
gous carcinomas of the breasts, skin and salivary glands. A
histologic and immunohistochemical comparison of ductal
mammary carcinoma, ductal sweat gland carcinoma and sal-
ivary duct carcinoma.  Am J Clin Pathol 1998, 109:75-84.
5. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG,
Morrow M: AJCC Cancer Staging Manual 6th edition. New York,
Springer Verlag; 2002. 
6. Yaziji H, Gown AM, Sneige N: Detection of stromal invasion in
breast cancer: the myoepithelial markers.  Adv Anat Pathol
2000, 7:100-109.
7. Zhou M, Shah R, Shen R, Rubin MA: Basal cell cocktail
(34betaE12 + p63) improves the detection of prostate basal
cells.  Am J Surg Pathol 2003, 27:365-71.
